Pharmacotherapy in pediatric neurogenic bladder intravesical botulinum toxin type a.

Abstract

When the neurogenic bladder is refractory to anticholinergics, botulinum toxin type A is used as an alternative. The neurotoxin type A reduces bladder pressure and increases its capacity and wall compliance. Additionally, it contributes to improving urinary continence and quality of life. This novel therapy is ambulatory with a low incidence of adverse effects. Due to its transitory effect, it is necessary to repeat the injections in order to sustain its therapeutic effect. In these review article we talk about Mechanism of Action, Indications, effects, administration and presentations of the Botulinum Neurotoxin Type A in pediatric patients. Also, we make references to controversial issues surrounding its use. A bibliographic search was done selecting articles and revisions from Pubmed. The key words used were botulinum toxin A, neurogenic bladder, and children. The search was limited to patients younger than 18 years of age and reports written in English in the past ten years.

• Authors: Cristian Sager, Carol Burek, Victor Durán, Juan Pablo Corbetta, Santiago Weller, Bortagaray Juan, Juan Carlos López
• Journal: ISRN urology (ISRN Urol) Vol. 2012 Pg. 763159 ( 2012) ISSN: 2090-5815 [Electronic] Egypt
• PMID: 22720170 (Publication Type: Journal Article)